A study shows that SP genes play a key role in limb and organ regeneration, and a novel gene therapy approach partially ...
Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency AskBio Inc. (AskBio), a ...
Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S.
Pfizer and BioMarin have pulled their hemophilia gene therapies, citing low demand. To prepare for his presentation at the ...
Sarepta Therapeutics Inc.'s bid for the full Federal Circuit’s review of a revived gene-therapy patent dispute with RegenxBio ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
Lokesh’s timely intervention, coordination, and assurance proved decisive in securing a ₹16-crore Zolgensma gene therapy ...
High co-payments for potentially curative cell and gene therapies create avoidable access barriers; value-based insurance ...
Labbit, a laboratory information management system (LIMS) built for regulated laboratories running complex workflows, today announced it has retired the Semaphore Solutions brand and consolidated ...
The draft guidance supports the agency’s new pathway designed to speed up the development of custom gene therapies.
Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics and AI-enabled design for RNA therapeutics, today announced the launch of its eCOMPASS™ lab-in-the-loop platform, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results